Assessment of a nonsteroidal aromatase inhibitor, letrozole, in juvenile rats

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 98, Issue 5, 2013, Pages 374-390

  Pouliot, Louise ^a   Schneider, Marilynn ^b   Decristofaro, Marc ^b   Samadfam, Rana ^a   Smith, Susan Y ^a   Beckman, David A ^b  

^a CHARLES RIVER LABORATORIES   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Bone effects; Juvenile toxicity; Letrozole; Postnatal development; Rat

Indexed keywords

LETROZOLE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BODY WEIGHT; BONE EXAMINATION; BONE GROWTH; BONE MATURATION; CONTROLLED STUDY; CROWN TO RUMP LENGTH; DRUG MECHANISM; ESTROGEN SYNTHESIS; FEMALE; FOOD INTAKE; IN VIVO STUDY; JUVENILE; MALE; NONHUMAN; OPHTHALMOLOGY; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PITUITARY ADRENAL GONADAL AXIS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; REPRODUCTION; SEX DIFFERENCE; SEXUAL MATURATION; TOXICOKINETICS; WEIGHT GAIN;

RATTUS;

BONE EFFECTS; JUVENILE TOXICITY; LETROZOLE; POSTNATAL DEVELOPMENT; RAT;

ANIMALS; AROMATASE INHIBITORS; BEHAVIOR, ANIMAL; BODY WEIGHT; BONE DEVELOPMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; FEMALE; MALE; MOTOR ACTIVITY; NITRILES; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCTION; SPERMATOZOA; TRIAZOLES;

EID: 84890314265     PISSN: 15429733     EISSN: 15429741     Source Type: Journal    
DOI: 10.1002/bdrb.21080     Document Type: Article

References (28)

1. Bajpai A, Simm PJ, McPherson SJ, Russo VC, Azar WJ, Wark JD, Risbridger GP, Werther GA. 2010. Peripubertal aromatase inhibition in male rats has adverse long-term effects on bone strength and growth and induces prostatic hyperplasia. J Endocrinol 207(1):27-34.
2. Bois C, Delalande C, Nurmio M, Parvinen M, Zanatta L, Toppari J, Carreau S. 2010. Age- and cell-related gene expression of aromatase and estrogen receptors in the rat testis. J Mol Endocrinol 45(3):147-159.
3. Cappon GD, Chapin RE, Hurtt ME, Wajnrajch MP, Burns-Naas LA. 2011. Impaired reproduction in adult male but not female, rats following juvenile treatment with the aromatase inhibitor, exemestrane. Birth Defects Res Pt B 92:304-313.
4. Carreau S, Hess RA. 2010. Oestrogens and spermatogenesis. Phil Trans R Soc B 365:1517-1519.
5. Carreau S, Wolczynski S, Galeraud-Denis I. 2010. Aromatase, oestrogens and human male reproduction. Phil Trans R Soc B 365:1571-1579.
6. Carreau S, Bouraima-Lelong H, Delalande C. 2011. Estrogens in male germ cells. Spermatogenesis 1(2):90-94.
7. Cohen MH, Johnson JR, Li N. 2002. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer. Clin Cancer Res 8:665-669.
8. Dunkel L. 2006. Use of aromatase inhibitors to increase final height. Mol Cell Endocrinol 254-255:207-216.
9. Dunkel L. 2010. Off-label use of aromatase inhibitors to promote taller stature: is it safe? Horm Res Paediatr 74:436-437.
10. Dunnett CW. 1955. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50:1096-1121.
11. Dunnett CW. 1964. New tables for multiple comparisons with a control. Biometrics 20:482-491.
12. Eshet R, Maor G, Ben Ari T, Ben Eliezer M, Gat-Yablonski G, Phillip M. 2004. The aromatase inhibitor letrozole increases epiphyseal growth plate height and tibial length in peripubertal male mice. J Endocrinol 182:165-172.
13. Folkestad L, Bjarnason NH, Bjerregaard JK, Brixen K. 2008. The effect of aromatase inhibitors on bone metabolism. Basic Clin Pharmacol Toxicol 104(1):3-10.
14. Hero M, Toiviainen-Salo S, Wickman S, Makitie O, Dunkel L. 2010. Vertebral morphology in aromatase inhibitor treated males with idiopathic short stature or constitutional delay of puberty. J Bone Miner Res 25:1536-1543.
15. Jesmin S, Mowa CN, Sakuma I, Matsuda N, Togashi H, Yoshioka M, Hattori Y, Kitabatake A. 2004. Aromatase is abundantly expressed by neonatal rat penis but downregulated in adulthood. J Mol Endocrinol 33(2):343-359.
16. Karimian E, Chagin AS, Gjerde J, Heino T, Lien EA, Ohlsson C, Savendahl L. 2008. Tamoxifen impairs both longitudinal and cortical bone growth in young male rats. J Bone Miner Res 23:1267-1277.
17. Kondarewicz A, Kolasa A, Zawiślak B, Baranowska-Bosiacka I, Marchlewicz M, Wenda-Rózewicka L, Wiszniewska B. 2011. Testis morphology in rats chronically treated with letrozole, an aromatase inhibitor. Folia Histochem Cytobiol 49(4):677-684.
18. Levene H. 1960. Robust tests for equality of variances. In: Olkin I, editor. Contributions to probability and statistics. Palo Alto, CA: Stanford University Press. p. 278-292.
19. Mowa CN, Iwanaga T. 2001. Expression of estrogen receptor-alpha and -beta mRNAs in the male reproductive system of the rat as revealed by in situ hybridization. J Mol Endocrinol 26(3):165-174.
20. Ryan KJ. 1982. Biochemistry of aromatase: significance to female reproductive physiology. Cancer Res 42(8 Suppl):3342s-3344s.
21. Shulman DI, Francis GL, Palmert MR, Eugster EA. 2008. Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development. Pediatrics 121(4):e975-e983.
22. Simpson ER. 2003. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86:225-230.
23. Simpson ER, Clyne C, Rubin G, Boon WC, Robertson K, Britt K, Speed C, Jones M. 2002. Aromatase-a brief overview. Annu Rev Physiol 64:93-127.
24. van Gool SA, Wit JM, De Schutter T, De Clerck, Postnov AA, Hovinger SK, van Doorn J, Veiga SJ, Garcia-Segura LM, Karperien M. 2010a. Impaired body weight and tail length gain and altered bone quality after treatment with the aromatase inhibitor exemestane in male rats. Horm Res Paediatr 73:376-385.
25. van Gool SA, Wit JM, De Schutter T, De Clerck, Postnov AA, Hovinger SK, van Doorn J, Veiga SJ, Garcia-Segura LM, Karperien M. 2010b. Marginal growth increase, altered bone quality and polycystic ovaries in female prepubertal rats after treatment with the aromatase inhibitor exemestane in male rats. Horm Res Paediatr 73:49-60.
26. Vanderschueren D, van HE, Nijs J, Ederveen AG, De CR, Bouillon R. 1997. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology 138:2301-2307.
27. Winer BJ. 1971. Statistical principles in experimental design. 2nd ed. New York: McGraw-Hill.
28. Wit JM, Hero M, Nunez SB. 2012. Aromatase inhibitors in pediatrics. Nat Rev Endocrinol 8:135-147.